Beyond Neuralink: How Brain-Computer Interfaces Are Evolving Today

The buzz around Neuralink has dominated headlines for years, but the reality of brain-computer interfaces (BCIs) is far richer and more diverse than any single company. While Elon Musk’s venture grabs attention with its futuristic implants, a quieter revolution is taking place — one that is more practical, more accessible, and already touching lives. From restoring movement to paralyzed patients to enabling communication for those locked in silence, BCIs are moving out of labs and into real-world applications. This article explores the current state of BCI development, drawing on recent news and established projects, to show that the future of mind-machine interaction is not just about Neuralink.

The BCI Landscape: More Than Implants

When most people hear "brain-computer interface," they imagine surgically implanted chips. But the field is far broader. Non-invasive BCIs, which use electrodes placed on the scalp (EEG), are already used in clinical settings and consumer products. Invasive BCIs, like those from Neuralink and others, offer higher signal fidelity but come with surgical risks. A third category — minimally invasive devices, such as stent-electrode arrays placed via blood vessels — is gaining traction. According to a recent report on Habr, the global BCI market is projected to exceed $5 billion by 2028, driven by neurorehabilitation, communication aids, and even entertainment.

Real-World Applications: From Paralysis to Play

One of the most compelling examples comes from the University of Pittsburgh Medical Center, where a patient with quadriplegia used an implanted BCI to control a robotic arm with thought alone. The system, based on a Utah array (a grid of tiny electrodes), allowed her to grasp objects and even feed herself. This is not a one-off: similar devices have been used in clinical trials for over a decade, with increasing reliability. In a recent study published in Nature Medicine, researchers demonstrated a wireless BCI that enabled a participant to type at 60 characters per minute — faster than many people can text.

On the non-invasive side, companies like MindRove and NextMind (now part of Snap) have developed headsets that allow users to control digital interfaces by focusing attention. For example, a person with ALS could select letters on a screen by staring at them, turning eye-tracking and brain signals into communication. These devices are now available for research and consumer use, with prices ranging from $500 to $2,000.

The News That Inspired This Article

A recent article on Habr (published July 2026) highlights how Russian researchers are advancing BCI technology for medical rehabilitation. The team at the Moscow Institute of Physics and Technology (MIPT) developed a non-invasive BCI that helps stroke survivors regain motor function. The system uses EEG to detect the patient’s intention to move, then triggers functional electrical stimulation (FES) to activate their muscles. In a pilot study with 20 participants, 70% showed significant improvement in hand movement within 12 weeks, compared to 30% in the control group. The authors emphasize that the system is low-cost and portable, making it suitable for home use. This is a prime example of how BCIs are moving beyond the hype and into practical therapy.

Source: Habr

Key Players and Technologies

To understand the BCI ecosystem, it helps to look at the diversity of approaches. The table below summarizes major players and their focus areas:

Notably, Synchron’s approach — inserting a stent-electrode into a blood vessel near the motor cortex — avoids open-brain surgery. In 2025, the company reported that a patient with ALS used its device to send WhatsApp messages just by thinking. This shows that BCI is no longer science fiction; it’s a tool for daily life.

Challenges and Ethical Considerations

Despite progress, BCIs face significant hurdles. Signal quality from non-invasive devices is often too noisy for precise control. Invasive implants carry risks of infection and long-term stability issues. There are also ethical concerns: who owns the neural data? Can someone’s thoughts be hacked? The BCI community is actively debating these questions. For instance, the IEEE has published ethical guidelines recommending that neural data be treated like medical records — requiring explicit consent and strong encryption.

Another challenge is cost. While consumer headsets are affordable, clinical-grade systems can cost tens of thousands of dollars. Insurance coverage remains limited, though some private insurers in the U.S. now cover BCI therapy for stroke patients. As the technology matures, economies of scale should bring prices down.

The Road Ahead

The future of BCIs is not just about Neuralink. It’s about a spectrum of solutions — from non-invasive headsets for daily use to implants for those with severe disabilities. The MIPT stroke rehabilitation project is a reminder that the most impactful applications may be those that help people regain basic functions, not just augment the healthy. In the next five years, expect to see more BCIs integrated into healthcare, education, and even entertainment. For instance, ASI Biont supports connecting to EEG devices through its API, enabling developers to build custom neurofeedback applications — learn more at asibiont.com/courses.

Conclusion

Brain-computer interfaces are no longer a distant dream. They are here, in labs, hospitals, and even living rooms. While Neuralink captures the imagination, the real progress lies in diverse, practical systems that are improving lives today. From stroke rehabilitation in Moscow to communication for ALS patients in Melbourne, BCIs are proving that the link between mind and machine is not just possible — it’s already changing the world.